article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. While the data was based on responses from 292 manufacturers across all sectors, the outcomes are applicable to pharmaceutical manufacturing. Meath opened last month.

article thumbnail

Tackling fake pharmaceuticals: an industry united against counterfeit products

European Pharmaceutical Review

Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. These may be mislabelled or produced in fake packaging and, most dangerously, there is no regulation around their manufacture. But what exactly does this look like? .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Optimising drug release of personalised 3D printed tablets

European Pharmaceutical Review

“The ability to predict dissolution curves based on tablet structure, and vice versa, holds promising prospects for tablet design and the application of 3D printing in pharmaceuticals”, the authors explained. their approach in the study addresses “diverse pharmaceutical manufacturing demands”.

article thumbnail

AmerisourceBergen agrees to acquire PharmaLex for $1.29bn

Pharmaceutical Technology

The PharmaLex takeover will build upon the current European presence of AmerisourceBergen in pharmaceutical supply and biopharma manufacturer services expertise. This latest development will progress various AmerisourceBergen’s strategic imperatives and bolster its position to gain substantial growth prospects in the biopharma market.

article thumbnail

Cleanroom microbiology: single-temperature incubation for EM

European Pharmaceutical Review

Future prospects This study shows that it is possible to choose single-temperature incubation in a pharmaceutical environment, thanks to the efficiency demonstrated in this study. The choice of incubation temperature must be based on data adapted to the specific environment.

article thumbnail

Solving pharma’s process development challenges one API at a time

Pharmaceutical Technology

The discovery of a new chemical entity (NCE) that could potentially lead the way to a ground-breaking therapeutic treatment is an exciting prospect for any chemist. If clinical trials prove successful, that same process should then be scaled to commercial manufacturing.

Safety 52
article thumbnail

Top 5 Emerging Trends in Pharma Industry

Medico Reach

The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. billion by 2027.

Pharma 52